Gregory Thomas Lucier
Independent DirectorMr. Gregory Thomas Lucier, also known as Greg, is Founder at Corza Medical Inc. and is its Executive Chairman and is its Chief Executive Officer. Mr. Lucier is Director of Avantor, Inc. from October 2025. He was Independent Director of Catalent, Inc. from April 2015 to December 18, 2024. He joined Catalent, Inc. in April 2015. He is Director of Antylia Scientific. He serves as a Director at Patriot Acquisition Bidco Ltd. since March 31, 2025. He serves as independent chairman of the board at Bruker Cellular Analysis, Inc. since May 14, 2021 until October 2, 2023. He is Founder of Corza Health, Inc. (“Corza Health”) and has been its Chief Executive Officer since April 2019 and Executive Chairman since February 2021. He is Chairman of the Board at Pleno, Inc. He is Director at Ventoux CCM Acquisition Corp. since November 19, 2020. He has been a Director of Maravai Life Sciences Inc. since January 2020. He has been Independent Director of Berkeley Lights, Inc. since June 2020 and has been its Chairman of the Board since May 14, 2021. Prior to Corza Health, he was Chairman and Chief Executive Officer of NuVasive, Inc. (“NuVasive”) from June 2015 to November 2018. He serves as Corporate Advisor of Organovo Holdings, Inc. since August 6, 2014. He served as an Interim Chief Executive Officer of NuVasive, Inc. from March 27, 2015 to May 21, 2015. He is Limited Partner of Lakeshore Capital Partners, LLC. He has substantial expertise in advising and managing multi-national companies with multiple business units, substantial experience with pharmaceutical and other healthcare companies and has substantial experience reviewing and analyzing executive compensation programs. He spent few years at Life Technologies. Prior to joining Nuvasive, Inc. in March 2015, he served as Chairman and Chief Executive Officer of Life Technologies Corporation (formerly, Invitrogen Corporation) since November 2008 until February 2014. He was associated with General Electric Corporation. He served as the Chief Executive Officer and President of Invitrogen Corp. since May 30, 2003. He served as the Chief Executive Officer and President at GE Medical Systems Information Technologies Gmbh from June 2000 to May 2003. From August 1999 to June 2000, he served as a Vice President, Global Services of GE Medical Systems. From May 1995 to August 1999, he served as the President of GE-Harris Railway Electronics. He was a Corporate Officer of General Electric Company where he served in a variety of leadership roles from 1994 to 2003. He served as Director and Chairman of NuVasive, Inc from March 2015 until May 18, 2021. He was employed at Data Critical Corporation. He has been an Independent Director of DENTSPLY SIRONA Inc. since May 22, 2019 and serves as its Chairman from January 1, 2024. He has been Chairman of Epic Sciences Inc. since July 30, 2014. He was the Chairman of Invuity, Inc. since December 31, 2015 until October 22, 2018 and its Independent Director since October 2014 until October 22, 2018. He served as the Chairman of BIOCOM, Inc. He served as the Chairman of Invitrogen Corp. He served as the Chairman of Sanford Burnham Prebys Medical Discovery Institute from September 2013 to December 16, 2016 and serves as its Trustee. He has been a Director of Catalent Pharma Solutions, Inc. since April 30, 2015 and Invitrogen since May 30, 2003. He serves as a Trustee of Sanford Burnham Prebys Medical Discovery Institute. He serves as a Director of Biocom SA, RT Oncology Services Corporation and NuVasive Corporation. He serves as Director of Biotechnology Industry Organization. He served as a Director of CareFusion Corporation from June 9, 2009 to March 17, 2015. He serves as an Independent Director of Maravai Life Sciences Holdings, LLC since January 2020 and Maravai LifeSciences Holdings, Inc. since November 19, 2020. He served as a Director at Care Fusion, Inc and Synthetic Genomics, Inc. He served as a Director of Life Technologies Corporation from May 2003 to February 2014. He is actively involved with the Business Roundtable in Washington D.C. and at San Diego State University as a distinguished lecturer. He served as President, Medical Information Technologies/GE Healthcare, overseeing the networking of medical electronic devices, digital imaging and clinical information systems with revenues of 1.8 billion. He was promoted by the GE Board to an officer of General Electric Corporation to serve as Vice President Global Services. He has served as a member of MLSH 1’s board since January 2020. He served as director of PhenomeX (formerly Berkeley Lights) from December 2021 to September 2023. He received his BA in Industrial Engineering from Pennsylvania State University and an MBA from Harvard Business School.
Positions
- Company NameMaravai LifeSciences Holdings, Inc.Stock CodeMRVIPositionIndependent DirectorColleagues
- RARobert Andrew EckertChairman of the Board
- BBBernd BrustCEO & Director
- RJRajesh J. AsorpotaEVP & Chief Financial Officer
- KAKurt A. OreshackExecutive VP, General Counsel & Secretary
- CDChristine DolanExecutive VP & GM of Cygnus Technologies
- SGSusannah GrayIndependent Director
- JAJohn A. DeFordIndependent Director
- GTGregory Thomas LucierIndependent Director
- Company NameDENTSPLY SIRONA Inc.Stock CodeXRAYPositionIndependent ChairmanColleagues
- DTDaniel T. ScavillaPresident, CEO, Interim Principal Financial Officer & Director
- ALAndrea L. FrohningSenior VP & Chief Human Resources Officer
- RARobert Anthony JohnsonSenior VP & Chief Supply Chain Officer
- AMAldo M. DentiExecutive VP & Chief Commercial Officer
- JCJohn C. FortsonExecutive VP & CFO
- BDBetsy D. HoldenIndependent Director
- JJJonathan J. MazelskyIndependent Director
- BTBrian T. GladdenIndependent Director
